These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 13736377)
1. [The effect of some estrogens on the serum copper content, especially in Wilson's disease]. PLOOIJ M; van der MEER ; KAAG A Ned Tijdschr Geneeskd; 1961 Mar; 105():471-6. PubMed ID: 13736377 [No Abstract] [Full Text] [Related]
2. Serum selenium concentration in patients with Wilson's disease. Swiatkowska-Stodulska R; Dejneka W; Jabłońska-Kaszewska I; Lukasiak J; Kiszkis H; Wiśniewski P; Lubińska M; Sworczak K Hepatogastroenterology; 2007 Sep; 54(78):1788-90. PubMed ID: 18019719 [TBL] [Abstract][Full Text] [Related]
3. [The onset of psychiatric disorders and Wilson's disease]. Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784 [TBL] [Abstract][Full Text] [Related]
4. A study on the concentrations of serum zinc, non-ceruloplasmin copper, reactive oxygen and nitrogen species in children with Wilson's disease. Geetha A; Jeyachristy SA; Selvamathy SM; Ilavarasi S; Surendran R Clin Chim Acta; 2007 Aug; 383(1-2):165-7. PubMed ID: 17573059 [No Abstract] [Full Text] [Related]
5. Contribution to the data on copper concentration in blood and urine in patients with Wilson's disease and in normal subjects. Lech T; Sadlik JK Biol Trace Elem Res; 2007 Jul; 118(1):16-20. PubMed ID: 17848726 [TBL] [Abstract][Full Text] [Related]
6. Significance of copper determination in late onset of Wilson's disease. Lech T; Hydzik P; Kosowski B Clin Toxicol (Phila); 2007 Sep; 45(6):688-94. PubMed ID: 17849244 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of oxidant stress in Wilson's disease and non-Wilsonian chronic liver disease in childhood. Dalgiç B; Sönmez N; Biberoğlu G; Hasanoğlu A; Erbaş D Turk J Gastroenterol; 2005 Mar; 16(1):7-11. PubMed ID: 16252181 [TBL] [Abstract][Full Text] [Related]
8. [Wilson's disease]. Kovacević I; Zekan M Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469 [TBL] [Abstract][Full Text] [Related]
9. [Abnormal platelet function in Wilson's disease]. Cohen AM; Creter D; Klein B; Lewinski UH; Djaldetti M Harefuah; 1982 Sep; 103(5-6):101-2. PubMed ID: 7169171 [No Abstract] [Full Text] [Related]
10. [Pathogenesis and treatment of Wilson's disease]. Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036 [TBL] [Abstract][Full Text] [Related]
12. Two male patients with Wilson's disease treated using trientine and iron reduction therapy. Hayashi H; Ueno T; Yano M; Okada T; Mabuchi H J Gastroenterol Hepatol; 2005 Oct; 20(10):1627-8. PubMed ID: 16174091 [No Abstract] [Full Text] [Related]
13. Is low serum tocopherol in Wilson's disease a significant symptom? Sinha S; Christopher R; Arunodaya GR; Prashanth LK; Gopinath G; Swamy HS; Taly AB J Neurol Sci; 2005 Feb; 228(2):121-3. PubMed ID: 15694191 [TBL] [Abstract][Full Text] [Related]
14. Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson's disease. Wang XP; Yang RM; Ren MS; Sun BM Funct Neurol; 2003; 18(3):149-53. PubMed ID: 14703896 [TBL] [Abstract][Full Text] [Related]